Close Menu

NEW YORK – 10x Genomics reported after the close of the market on Tuesday a 49 percent increase in fourth quarter revenues that was driven by consumables sales.

For the three months ended Dec. 31, the Pleasanton, California-based single-cell analysis technologies firm reported $112.2 million in revenues, up from $75.3 million during the prior-year period and beating the average Wall Street estimate of $100.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.